The majority of deaths caused by the flu can be traced back to one simple cause, respiratory failure.
Respiratory failure is the common trigger that causes the majority of elderly deaths and the trauma that is seen from rare super strains acting on populations throughout the globe. As the flu progresses, a thin layer of cells that separates the lungs from the blood stream begins to break down. When the flu reaches its most serious stages, this thin layer can break down, which in turn causes fluids to leak into the lungs. This fluid leakage can create a situation known as acute respiratory distress syndrome. This condition exists when enough fluid leaks into the lungs that a drowning like situation can occur in which the lungs are not capable of receiving enough oxygen to survive.
There is Not a Treatment in Existence That Works Well Against the Flu
While flu vaccines do exist, they are not always effective in treating the virus as it has the potential to mutate and change in ways that doctors cannot predict. There are millions of severe and debilitating flu cases every year and it is estimated that around 35,000 people die from the sickness annually. Tamiflu is one of the best options on the market, but even as the most popular drug it still has less than stellar results when helping people fight the flu. As the virus wears down the body, the best option for treatment often lies in supportive care and one’s own immune system.
A New Treatment Called Vasculotide Works by Not Treating the Flu at All
Instead of fighting the virus itself, Vasculotide acts on the lungs to prevent fluid from leaking into them. By giving the body extra time and preventing acute respiratory distress syndrome from occurring, the body’s immune system can gain some valuable time to fight off the flu on its own. Vasculotide achieves this by preventing the cell death inside the lungs that is commonplace among flu victims. This treatment option is contradictory to what many scientists have believed for years. It was thought for a long time that by only fighting the symptoms, little would be done to fight off the sickness itself. As it turns out, this is not the case. This treatment does not do anything to strengthen the body’s immune system, but rather works to give the body’s natural defenses more time. This treatment was discovered at the University of Toronto and lead by researcher and clinician, Warren L Lee. The team of researchers from Toronto believes that it could be possible for a highly potent strain of the flu virus to come into existence in the future. In 1918, a strain of this strength wiped out around 50 million people due to its extreme severity and the inability of many people to fight it off. With a treatment like Vasculotide, the researchers hope that even if a super strain of the flu were to come back into existence, people would still be able to fight it off. Lee and some members of his team have filed a patent for this treatment option and hope to continue researching and developing the method.